Group One Trading’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$879 Sell
73
-360
-83% -$6.99K ﹤0.01% 7169
2026
Q2
$10.3K Sell
433
-1,695
-80% -$44.3K ﹤0.01% 6378
2026
Q1
$66.4K Buy
2,128
+283
+15% +$9.6K ﹤0.01% 5056
2025
Q4
$57.8K Sell
1,845
-7,430
-80% -$244K ﹤0.01% 5484
2025
Q3
$268K Buy
9,275
+8,415
+978% +$1.53M ﹤0.01% 4357
2025
Q2
$174K Sell
860
-3,480
-80% -$548K ﹤0.01% 4476
2025
Q1
$524K Buy
+4,340
New +$633K ﹤0.01% 3039
2023
Q3
– Sell
-55
Closed -$4.75K – 8424
2023
Q2
$4.75K Buy
+55
New +$4.8K ﹤0.01% 6741
2022
Q4
– Sell
-565
Closed -$68K – 8234
2022
Q3
$68K Buy
565
+142
+34% +$19K ﹤0.01% 5145
2022
Q2
$48K Sell
423
-182
-30% -$26.3K ﹤0.01% 5594
2022
Q1
$129K Buy
605
+337
+126% +$76.4K ﹤0.01% 5252
2021
Q4
$80K Buy
268
+85
+46% +$28.4K ﹤0.01% 5929
2021
Q3
$66K Buy
+183
New +$43.8K ﹤0.01% 6319

Other funds holding ATYR

Group One Trading's ATYR Position: Q3 2026 in Review

Group One Trading reduced its aTyr Pharma (ATYR) stake by 36% in Q3 2026, selling an estimated $24K and leaving 2,237 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5668.

Group One Trading first reported a position in ATYR in Q2 2019 and has held it in 20 quarters since. The position peaked at $359K in Q2 2025. 68 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

  • Group One Trading held 2,237 shares of aTyr Pharma worth $27.1K as of Q3 2026.
  • Group One Trading sold 1,235 aTyr Pharma shares in Q3 2026, an estimated $24K.
  • aTyr Pharma made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5668 holding.
  • Group One Trading first reported a position in aTyr Pharma in Q2 2019 and has held it in 20 quarters since.
  • Group One Trading's aTyr Pharma position peaked at $359K in Q2 2025.
  • 68 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.